Skip to main content
Premium Trial:

Request an Annual Quote

Swift Biosciences ACE2 Swift Normalase Amplicon Panel

Swift Biosciences has launched the ACE2 Swift Normalase Amplicon Panel, a next-generation sequencing library preparation assay for use in research on COVID-19.

ACE2 is the key receptor for entry of the SARS-CoV-2 virus into human cells.

The Swift panel uses single-tube multiplex PCR and offers 100 percent coverage of coding sequences. It can generate libraries from low input quantities of DNA and libraries can be quantified or normalized using Normalase reagents.

Data analysis and interpretation are available through Swift's VarSome platform.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.